Conditions: Anemia
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 11
Healthy volunteers: no

Brief summary:
The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.

Detailed description:

Arms:
arm 1: All subjects who received study drug and completed Pharmacokinetic testing through 24 hours post-dose.

Interventions: intervention 1: Venofer
Intervention descriptions: intervention 1: Single dose of 7mg intravenous (IV) of iron per kg of body weight for a maximum of 200mg iron IV.

Protocol document: